rss
Br J Ophthalmol 81:431-434 doi:10.1136/bjo.81.6.431
  • Original Article
    • Clinical science

HLA antigens in Omanis with blinding trachoma: markers for disease susceptibility and resistance

Table 3

Class II DNA/HLA DQ β1 typing of trachoma patients and controls

HLA antigen Trachoma patients (n=46) Controls (n=100) RR χ2 p Value pc
pos neg pos neg
DQB0501 5 41 13 87 0.86 0.132 0.716 10.020
DQB0502 38 8 63 37 2.67 5.682 0.018 0.252
DQB0503 2 44 1 99 3.72 0.234 3.276
DQB0601 2 44 8 92 0.61 0.506 7.084
DQB0602 4 42 8 92 1.15 0.558 7.812
DQB0603/0607 3 43 5 95 1.40 0.488 6.832
DQB0604/0609 1 45 2 98 1.30 0.682 9.548
DQB0201/0202 14 32 27 73 1.19 0.184 0.668 9.352
DQB0301 2 44 11 89 0.44 0.159 2.226
DQB0302 0 46 8 92 0.12 0.044 0.616
DQB0303 1 45 1 99 2.20 0.532 7.448
DQB0304 1 45 0 100 6.62 0.315 4.410
DQB0401 0 46 0 100 2.16
DQB0402 1 45 3 97 0.92 0.625 8.750
  • When numbers are small Fisher’s exact test applied.

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.